Kirk Allen Coleman - 03 Jul 2024 Form 4 Insider Report for TFF Pharmaceuticals, Inc.

Reporting relationship: Chief Financial Officer
Issuer ticker: N/A
Reported as of: 03 Jul 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Jul 2024, 17:43:16 UTC
Prior SEC filing: 22 Apr 2024
Source filing: View source filing
Reporting owner signature: /s/ Kirk Allen Coleman

Key filing fact

Kirk Allen Coleman filed Form 4 for TFF Pharmaceuticals, Inc. on 08 Jul 2024.

Key facts

This page summarizes Kirk Allen Coleman's Form 4 filing for TFF Pharmaceuticals, Inc..
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 08 Jul 2024, 17:43.

Change

Previous filing in this sequence was filed on 22 Apr 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TFFP transaction

Common Stock

Award

Transaction value: $0
Shares: +10,184
Change %: +29%
Price: $0.000000
Shares after: 45,859
Date: 03 Jul 2024
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TFFP transaction Derivative

Stock Options (Right to Buy)

Award

Transaction value: $0
Shares: +10,184
Change %
Price: $0.000000
Shares after: 10,184
Date: 03 Jul 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,184
Exercise price: $1.82
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents shares of common stock underlying restricted stock units ("RSUs"). Each RSU entitles its holder to receive one Common Stock of the issuer. The RSUs will vest and be settled in sixteen equal quarterly installments with a one-year cliff.

Footnote F2

One-quarter of the options vest and first become exercisable on June 19, 2025 and the remainder of the options vest and first become exercisable in 12 equal quarterly installments commencing on September 19, 2025.